Hydroxyurea and Leukaemia recurrent - a phase IV clinical study of FDA data

Summary:

Leukaemia recurrent is reported as a side effect among people who take Hydroxyurea (hydroxyurea), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Glivec, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Leukaemia recurrent when taking Hydroxyurea. It is created by eHealthMe based on reports of 16,937 people who have side effects when taking Hydroxyurea from the FDA, and is updated regularly.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

What is Leukaemia recurrent?

Leukaemia recurrent (repeat cancer of bone marrow or blood cells) is found to be associated with 165 drugs and 260 conditions by eHealthMe. Check the latest studies of Leukaemia recurrent.

On Aug, 10, 2026

16,937 people reported to have side effects when taking Hydroxyurea.
Among them, 13 people (0.08%) have Leukaemia recurrent.

Could Hydroxyurea cause Leukaemia recurrent?

Among these 13 people:

How long have people been on Hydroxyurea when they have Leukaemia recurrent? *

What is the gender of people who have Leukaemia recurrent when taking Hydroxyurea? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Leukaemia recurrent when taking Hydroxyurea? *

What are other drugs people take besides Hydroxyurea? *

What are other side effects people have besides Leukaemia recurrent? *

Thrombocytopenia (decrease of platelets in blood): 4 people, 30.77%
Drug Ineffective: 4 people, 30.77%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 23.08%
Death: 3 people, 23.08%
Fever: 3 people, 23.08%
White Blood Cell Count Increased: 2 people, 15.38%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 15.38%
Diarrhea: 2 people, 15.38%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 15.38%
Nausea And Vomiting: 2 people, 15.38%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 5 people, 38.46%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 38.46%
Tumor Lysis Syndrome: 1 person, 7.69%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 7.69%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
Depression: 1 person, 7.69%
Bone Pain: 1 person, 7.69%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyurea and have Leukaemia recurrent?

- Check whether Leukaemia recurrent is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydroxyurea:

Hydroxyurea (17,240 reports)

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukaemia recurrent:

Leukaemia recurrent (165 drugs)

Browse all the conditions that are associated with Leukaemia recurrent:

Leukaemia recurrent (260 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyurea (the active ingredients of Hydroxyurea) and Hydroxyurea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.